Simulating distal gut mucosal and luminal communities using packed-column biofilm reactors and an in vitro chemostat model

Journal of Microbiological Methods

Volumn 108, Issue , 2015, Pages 36-44

  McDonald, Julie A K ^a   Fuentes, Susana ^b   Schroeter, Kathleen ^a   Heikamp deJong, Ineke ^b   Khursigara, Cezar M ^a   de Vos, Willem M ^b   Allen Vercoe, Emma ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Biofilm; Chemostat; DGGE; HITChip; Human gut microbiota; Microbial ecology

Indexed keywords

CLINDAMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BACTEROIDES OVATUS; BACTEROIDES UNIFORMIS; BACTEROIDETES; BIOFILM REACTOR; CHEMOSTAT; CULTURE MEDIUM; CYANOBACTERIUM; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA EXTRACTION; ESCHERICHIA COLI; FIRMICUTES; FUSOBACTERIA; HUMAN; IN VITRO STUDY; INTESTINE FLORA; MICROARRAY ANALYSIS; MICROBIAL COMMUNITY; MUCOSA; PARABACTEROIDES DISTASONIS; PHYLOGENY; PLANKTON; PRINCIPAL COMPONENT ANALYSIS; PROTEOBACTERIA; STEADY STATE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM; BIOFILM; BIOLOGICAL MODEL; CLASSIFICATION; DRUG EFFECTS; GASTROINTESTINAL TRACT; GENETICS; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOFILMS; CLINDAMYCIN; GASTROINTESTINAL TRACT; HUMANS; INTESTINAL MUCOSA; MICROBIOTA; MODELS, BIOLOGICAL; PHYLOGENY;

EID: 84912034784     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2014.11.007     Document Type: Article

References (61)

1. Allen-Vercoe E., Petrof E.O. Artificial stool transplantation: progress towards a safer, more effective and acceptable alternative. Expert Rev. Gastroenterol. Hepatol. 2013, 7:291-293.
2. Allison C., McFarlan C., MacFarlane G.T. Studies on mixed populations of human intestinal bacteria grown in single-stage and multistage continuous culture systems. Appl. Environ. Microbiol. 1989, 55:672-678.
3. Anwar H., van Biesen T., Dasgupta M., Lam K., Costerton J.W. Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system. Antimicrob. Agents Chemother. 1989, 33:1824-1826.
4. Anwar H., Strap J.L., Chen K., Costerton J.W. Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob. Agents Chemother. 1992, 36:1208-1214.
5. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
6. Belzer C., de Vos W.M. Microbes inside-from diversity to function: the case of Akkermansia. ISME J. 2012, 6:1449-1458.
7. Booijink C.C., El-Aidy S., Rajilic-Stojanovic M., Heilig H.G., Troost F.J., Smidt H., et al. High temporal and inter-individual variation detected in the human ileal microbiota. Environ. Microbiol. 2010, 12:3213-3227.
8. Buffie C.G., Jarchum I., Equinda M., Lipuma L., Gobourne A., Viale A., et al. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect. Immun. 2012, 80:62-73.
9. Costerton J.W., Lewandowski Z., Caldwell D.E., Korber D.R., Lappin-Scott H.M. Microbial biofilms. Annu. Rev. Microbiol. 1995, 49:711-745.
10. Derrien M., Vaughan E.E., Plugge C.M., de Vos W.M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 2004, 54:1469-1476.
11. Duarte S., Cássio F., Pascoal C. Denaturing gradient gel electrophoresis (DGGE) in microbial ecology - insights from freshwaters. Gel Electrophoresis - Principles and Basics 2012, 173-196. InTech. S. Magdeldin (Ed.).
12. Duncan S.H., Scott K.P., Ramsay A.G., Harmsen H.J., Welling G.W., Stewart C.S., et al. Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system. Appl. Environ. Microbiol. 2003, 69:1136-1142.
13. Durban A., Abellan J.J., Jimenez-Hernandez N., Ponce M., Ponce J., Sala T., et al. Assessing gut microbial diversity from feces and rectal mucosa. Microb. Ecol. 2011, 61:123-133.
14. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., et al. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
15. Ferrera I., Sanchez O., Mas J. A new non-aerated illuminated packed-column reactor for the development of sulfide-oxidizing biofilms. Appl. Microbiol. Biotechnol. 2004, 64:659-664.
16. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13780-13785.
17. Freter R., Allweiss B., O'Brien P.C., Halstead S.A., Macsai M.S. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies. Infect. Immun. 1981, 34:241-249.
18. Freter R., O'Brien P.C., Macsai M.S. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect. Immun. 1981, 34:234-240.
19. Fromin N., Hamelin J., Tarnawski S., Roesti D., Jourdain-Miserez K., Forestier N., et al. Statistical analysis of denaturing gel electrophoresis (DGE) fingerprinting patterns. Environ. Microbiol. 2002, 4:634-643.
20. Gafan G.P., Lucas V.S., Roberts G.J., Petrie A., Wilson M., Spratt D.A. Statistical analyses of complex denaturing gradient gel electrophoresis profiles. J. Clin. Microbiol. 2005, 43:3971-3978.
21. Gaskins H.R., Croix J.A., Nakamura N., Nava G.M. Impact of the intestinal microbiota on the development of mucosal defense. Clin. Infect. Dis. 2008, 46(Suppl. 2):S80-6. (discussion S144-51).
22. Girvan M.S., Campbell C.D., Killham K., Prosser J.I., Glover L.A. Bacterial diversity promotes community stability and functional resilience after perturbation. Environ. Microbiol. 2005, 7:301-313.
23. Hong P.Y., Croix J.A., Greenberg E., Gaskins H.R., Mackie R.I. Pyrosequencing-based analysis of the mucosal microbiota in healthy individuals reveals ubiquitous bacterial groups and micro-heterogeneity. PLoS ONE 2011, 6:e25042.
24. Jalanka-Tuovinen J., Salonen A., Nikkila J., Immonen O., Kekkonen R., Lahti L., et al. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS ONE 2011, 6:e23035.
25. Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007, 1:56-66.
26. Kager L., Liljeqvist L., Malmborg A.S., Nord C.E. Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Antimicrob. Agents Chemother. 1981, 20:736-740.
27. Lawley T.D., Clare S., Walker A.W., Stares M.D., Connor T.R., Raisen C., et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012, 8:e1002995.
28. Macfarlane S., Woodmansey E.J., Macfarlane G.T. Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl. Environ. Microbiol. 2005, 71:7483-7492.
29. Magurran A.E. Measuring Biological Diversity Measuring Biological Diversity 2004, Blackwell Science Ltd., Malden, MA, USA.
30. Marzorati M., Wittebolle L., Boon N., Daffonchio D., Verstraete W. How to get more out of molecular fingerprints: practical tools for microbial ecology. Environ. Microbiol. 2008, 10:1571-1581.
31. McDonald J.A., Schroeter K., Fuentes S., Heikamp-Dejong I., Khursigara C.M., de Vos W.M., et al. Evaluation of microbial community reproducibility, stability and composition in a human distal gut chemostat model. J. Microbiol. Methods 2013, 95:167-174.
32. Muyzer G., de Waal E.C., Uitterlinden A.G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 1993, 59:695-700.
33. Nyberg S.D., Osterblad M., Hakanen A.J., Lofmark S., Edlund C., Huovinen P., et al. Long-term antimicrobial resistance in Escherichia coli from human intestinal microbiota after administration of clindamycin. Scand. J. Infect. Dis. 2007, 39:514-520.
34. Oteo J., Aracil B., Alos J.I., Gomez-Garces J.L. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates. J. Antimicrob. Chemother. 2000, 45:691-693.
35. Peterfreund G.L., Vandivier L.E., Sinha R., Marozsan A.J., Olson W.C., Zhu J., et al. Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile. PLoS ONE 2012, 7:e46966.
36. Petrof E.O., Claud E.C., Gloor G.B., Allen-Vercoe E. Microbial ecosystem therapeutics: a new paradigm in medicine?. Benefic. Microbes 2013, 4:53-65.
37. Petrof E.O., Gloor G.B., Vanner S.J., Weese J.S., Carter D., Daigneault M.C., et al. Stool substitute transplant therapy for the eradication of C. difficile infection: RePOOPulating the gut. Microbiome 2013, 1:1-12.
38. Pielou E.C. Ecological Diversity Ecological Diversity 1975, Wiley, New York.
39. Png C.W., Linden S.K., Gilshenan K.S., Zoetendal E.G., McSweeney C.S., Sly L.I., et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 2010, 105:2420-2428.
40. Possemiers S., Verthe K., Uyttendaele S., Verstraete W. PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol. Ecol. 2004, 49:495-507.
41. Probert H.M., Gibson G.R. Development of a fermentation system to model sessile bacterial populations in the human colon. Biofilms 2004, 1:13-19.
42. Rajilic-Stojanovic M., Heilig H.G., Molenaar D., Kajander K., Surakka A., Smidt H., et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ. Microbiol. 2009, 11:1736-1751.
43. Reeves A.E., Theriot C.M., Bergin I.L., Huffnagle G.B., Schloss P.D., Young V.B. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection. Gut Microbes 2011, 2:145-158.
44. Sanchez O., Ferrera I., Mas J. Laboratory model systems for the study of microbial communities. Microbial Ecology Research Trends 2008, 87-114. Nova Biomedical Books, New York. T. Van Dijk (Ed.).
45. Sekirov I., Russell S.L., Antunes L.C., Finlay B.B. Gut microbiota in health and disease. Physiol. Rev. 2010, 90:859-904.
46. Shen X.J., Rawls J.F., Randall T., Burcal L., Mpande C.N., Jenkins N., et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010, 1:138-147.
47. Shi L., Ardehali R., Caldwell K., Valint P. Mucin coating on polymeric material surfaces to suppress bacterial adhesion paper. Colloids Surf. B 2000, 17:229-239.
48. Smith C.J. Characterization of Bacteroides ovatus plasmid pBI136 and structure of its clindamycin resistance region. J. Bacteriol. 1985, 161:1069-1073.
49. Smith B., Wilson J.B. A consumer's guide to evenness indices. Oikos 1996, 76:70-82.
50. Sun J., Zhou T.T., Le G.W., Shi Y.H. Association of Lactobacillus acidophilus with mice Peyer's patches. Nutrition 2010, 26:1008-1013.
51. Swidsinski A., Dorffel Y., Loening-Baucke V., Theissig F., Ruckert J.C., Ismail M., et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 2011, 60:34-40.
52. Tannock G.W., Munro K., Harmsen H.J., Welling G.W., Smart J., Gopal P.K. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 2000, 66:2578-2588.
53. Van den Abbeele P., Grootaert C., Possemiers S., Verstraete W., Verbeken K., Van de Wiele T. In vitro model to study the modulation of the mucin-adhered bacterial community. Appl. Microbiol. Biotechnol. 2009, 83:349-359.
54. Van den Abbeele P., Grootaert C., Marzorati M., Possemiers S., Verstraete W., Gerard P., et al. Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX. Appl. Environ. Microbiol. 2010, 76:5237-5246.
55. Van den Abbeele P., Van de Wiele T., Verstraete W., Possemiers S. The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept. FEMS Microbiol. Rev. 2011, 35:681-704.
56. Van den Abbeele P., Belzer C., Goossens M., Kleerebezem M., De Vos W.M., Thas O., et al. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 2012, 7:949-961.
57. Van den Abbeele P., Roos S., Eeckhaut V., MacKenzie D.A., Derde M., Verstraete W., et al. Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli. Microb. Biotechnol. 2012, 5:106-115.
58. Vermeiren J., Van den Abbeele P., Laukens D., Vigsnaes L.K., De Vos M., Boon N., et al. Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. FEMS Microbiol. Ecol. 2012, 79:685-696.
59. Wang Y., Antonopoulos D.A., Zhu X., Harrell L., Hanan I., Alverdy J.C., et al. Laser capture microdissection and metagenomic analysis of intact mucosa-associated microbial communities of human colon. Appl. Microbiol. Biotechnol. 2010, 88:1333-1342.
60. Willing B.P., Dicksved J., Halfvarson J., Andersson A.F., Lucio M., Zheng Z., et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010, 139:1844-1854.e1.
61. Zoetendal E.G., von Wright A., Vilpponen-Salmela T., Ben-Amor K., Akkermans A.D., de Vos W.M. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 2002, 68:3401-3407.